Patents by Inventor Patricia Greenhalgh

Patricia Greenhalgh has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method of determining virus removal from a sample containing a target protein using activated carbon
    Patent number: 9910041
    Abstract: The present invention provides methods for determining whether activated carbon can be used for removing viruses or a certain virus from a sample containing a target protein.
    Type: Grant
    Filed: April 4, 2014
    Date of Patent: March 6, 2018
    Assignee: EMD Millipore Corporation
    Inventors: Matthew T. Stone, Ushma Mehta, Damon Asher, Patricia Greenhalgh
  • A METHOD OF DETERMINING VIRUS REMOVAL FROM A SAMPLE CONTAINING A TARGET PROTEIN USING ACTIVATED CARBON
    Publication number: 20160123981
    Abstract: The present invention provides methods for determining whether activated carbon can be used for removing viruses or a certain virus from a sample containing a target protein.
    Type: Application
    Filed: April 4, 2014
    Publication date: May 5, 2016
    Applicant: EMD MILLIPORE CORPORATION
    Inventors: Matthew T. STONE, Ushma MEHTA, Damon ASHER, Patricia GREENHALGH
  • Modified CEA nucleic acid and expression vectors
    Patent number: 8530442
    Abstract: The present invention relates to a nucleic acid encoding a polypeptide and the use of the nucleic acid or polypeptide in preventing and/or treating cancer. The invention relates to improved vectors for the insertion and expression of foreign genes encoding tumor antigens for use in immunotherapeutic treatment of cancer. One such foreign DNA sequence is modified CEA nucleic acid.
    Type: Grant
    Filed: June 25, 2012
    Date of Patent: September 10, 2013
    Assignee: Sanofi Pasteur Limited
    Inventors: Mark Parrington, Linong Zhang, Benjamin Rovinski, Linda R. Gritz, Patricia Greenhalgh
  • MODIFIED CEA NUCLEIC ACID AND EXPRESSION VECTORS
    Publication number: 20130101625
    Abstract: The present invention relates to a nucleic acid encoding a polypeptide and the use of the nucleic acid or polypeptide in preventing and/or treating cancer. The invention relates to improved vectors for the insertion and expression of foreign genes encoding tumor antigens for use in immunotherapeutic treatment of cancer. One such foreign DNA sequence is modified CEA nucleic acid.
    Type: Application
    Filed: June 25, 2012
    Publication date: April 25, 2013
    Inventors: Mark Parrington, Linong Zhang, Benjamin Rovinski, Linda R. Gritz, Patricia Greenhalgh
  • Modified CEA nucleic acid and expression vectors
    Patent number: 8236776
    Abstract: The present invention relates to a nucleic acid encoding a polypeptide and the use of the nucleic acid or polypeptide in preventing and/or treating cancer. The invention relates to improved vectors for the insertion and expression of foreign genes encoding tumor antigens for use in immunotherapeutic treatment of cancer. One such foreign DNA sequence is modified CEA nucleic acid.
    Type: Grant
    Filed: March 2, 2010
    Date of Patent: August 7, 2012
    Assignee: Sanofi Pasteur Limited
    Inventors: Mark Parrington, Linong Zhang, Benjamin Rovinski, Linda R. Gritz, Patricia Greenhalgh
  • MODIFIED CEA NUCLEIC ACID AND EXPRESSION VECTORS
    Publication number: 20100285065
    Abstract: The present invention relates to a nucleic acid encoding a polypeptide and the use of the nucleic acid or polypeptide in preventing and/or treating cancer. The invention relates to improved vectors for the insertion and expression of foreign genes encoding tumor antigens for use in immunotherapeutic treatment of cancer. One such foreign DNA sequence is modified CEA nucleic acid.
    Type: Application
    Filed: March 2, 2010
    Publication date: November 11, 2010
    Inventors: Mark Parrington, Linong Zhang, Benjamin Rovinski, Linda R. Gritz, Patricia Greenhalgh
  • Modified CEA nucleic acid and expression vectors
    Patent number: 7786278
    Abstract: The present invention relates to a nucleic acid encoding a polypeptide and the use of the nucleic acid or polypeptide in preventing and/or treating cancer. The invention relates to improved vectors for the insertion and expression of foreign genes encoding tumor antigens for use in immunotherapeutic treatment of cancer. One such foreign DNA sequence is modified CEA nucleic acid.
    Type: Grant
    Filed: April 9, 2003
    Date of Patent: August 31, 2010
    Inventors: Mark Parrington, Linong Zhang, Benjamin Rovinski, Linda R. Gritz, Patricia Greenhalgh
  • NOVEL INSERTION SITES IN POX VECTORS
    Publication number: 20100136056
    Abstract: The present invention provides novel insertion sites for introducing DNA into pox vectors.
    Type: Application
    Filed: December 16, 2009
    Publication date: June 3, 2010
    Applicant: The United States of America, as represented by the Secretary, Dept. of Health and Human Services
    Inventors: Dennis L. Panicali, Gail P. Mazzara, Linda R. Gritz, Patricia Greenhalgh
  • Insertion sites in fowlpox vectors
    Patent number: 7638134
    Abstract: The present invention provides novel insertion sites for introducing DNA into pox vectors.
    Type: Grant
    Filed: February 20, 2004
    Date of Patent: December 29, 2009
    Assignee: The United States of America as represented by the Secretary of the Department of Health and Human Services
    Inventors: Dennis L. Panicali, Gail P. Mazzara, Linda R. Gritz, Patricia Greenhalgh
  • Novel insertion sites in pox vectors
    Publication number: 20060159706
    Abstract: The present invention provides novel insertion sites for introducing DNA into pox vectors.
    Type: Application
    Filed: February 20, 2004
    Publication date: July 20, 2006
    Inventors: Dennis Panicali, Gail Mazzara, Linda Gritz, Patricia Greenhalgh